Literature DB >> 19636214

P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.

R Gen1, E Akbay, A Camsari, T Ozcan.   

Abstract

BACKGROUND: The aim of this study was to measure maximum P wave duration (Pmax) and P wave dispersion (PWD), which can be indicators for the risk of paroxysmal atrial fibrillation when increased, and to reveal their relationship with thyroid hormone levels in patients with endogenous and exogenous subclinical hyperthyroidism.
METHODS: Seventy-one patients with sublinical thyrotoxicosis (34 endogenous, 37 exogenous) and 69 healthy individuals were enrolled in the study. Pmax and minimum P wave duration (Pmin) on electrocardiogram recordings were measured and PWD was calculated as Pmax-Pmin.
RESULTS: Pmax (p<0.001) and PWD (p<0.001) values were significantly higher in patients with endogenous subclinical hyperthyroidism compared with the control group. Pmax (p<0.001) and PWD (p<0.001) values were significantly higher in patients with exogenous subclinical thyrotoxicosis compared with the control group. Pmax (p=0.710) and PWD (p=0.127) were not significantly different in patients with endogenous subclinical hyperthyroidism compared with exogenous subclinical hyperthyroid patients. Pmax and PWD negatively associated with TSH in endogenous and exogenous subclinical hyperthyroidism.
CONCLUSION: In the present study, we observed that Pmax and PWD were longer in patients with endogenous and exogenous subclinical hyperthyroidism. Lack of a difference in Pmax and PWD between patients with endogenous and exogenous subclinical hyperthyroidism seems to support the idea that hormone levels rather than the etiology of thyrotoxicosis affect the heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636214     DOI: 10.1007/BF03346559

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes.

Authors:  P E Dilaveris; G K Andrikopoulos; G Metaxas; D J Richter; C K Avgeropoulou; A M Androulakis; E J Gialafos; A P Michaelides; P K Toutouzas; J E Gialafos
Journal:  Pacing Clin Electrophysiol       Date:  1999-11       Impact factor: 1.976

2.  Clinical case seminar: Reentrant atrioventricular nodal tachycardia induced by levothyroxine.

Authors:  B Biondi; S Fazio; F Coltorti; E A Palmieri; C Carella; G Lombardi; L Saccà
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

3.  The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.

Authors:  José A Sgarbi; Fábio G Villaça; Benito Garbeline; Heloísa E Villar; João H Romaldini
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation.

Authors:  J Auer; P Scheibner; T Mische; W Langsteger; O Eber; B Eber
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

5.  The role of P wave in prediction of atrial fibrillation after coronary artery surgery.

Authors:  C M Chang; S H Lee; M J Lu; C H Lin; H H Chao; J J Cheng; P Kuan; C R Hung
Journal:  Int J Cardiol       Date:  1999-03-15       Impact factor: 4.164

Review 6.  Subclinical thyroid disease.

Authors:  George R Wilson; R Whit Curry
Journal:  Am Fam Physician       Date:  2005-10-15       Impact factor: 3.292

7.  How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators.

Authors:  A D Krahn; G J Klein; C R Kerr; J Boone; R Sheldon; M Green; M Talajic; X Wang; S Connolly
Journal:  Arch Intern Med       Date:  1996-10-28

Review 8.  Effects of subclinical thyroid dysfunction on the heart.

Authors:  Bernadette Biondi; Emiliano A Palmieri; Gaetano Lombardi; Serafino Fazio
Journal:  Ann Intern Med       Date:  2002-12-03       Impact factor: 25.391

9.  Effects of thyroid hormone on sodium pump sites, sodium content, and contractile responses to cardiac glycosides in cultured chick ventricular cells.

Authors:  D Kim; T W Smith
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism.

Authors:  A Montereggi; P Marconi; I Olivotto; G Castelli; A Dolara; M L Luisi; R G Gheri
Journal:  Am J Cardiol       Date:  1996-02-01       Impact factor: 2.778

View more
  4 in total

1.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients.

Authors:  Katerina Pizzuto; Henry L Averns; Adrian Baranchuk; Hoshiar Abdollah; Kevin A Michael; Christopher Simpson; Damian P Redfearn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09-24       Impact factor: 1.468

Review 3.  Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature.

Authors:  William Ae Parker; Ovie Edafe; Sabapathy P Balasubramanian
Journal:  Pragmat Obs Res       Date:  2017-05-16

Review 4.  Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism.

Authors:  Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.